FdaApplication
NDA 218139
Identifiers
- fda_app_no: NDA218139
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | NDA |
| approval_date | 2024-07-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TEZRULY | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE/ML | SOLUTION;ORAL |
1 product